El-Arif, G.; Khazaal, S.; Farhat, A.; Harb, J.; Annweiler, C.; Wu, Y.; Cao, Z.; Kovacic, H.; Abi Khattar, Z.; Fajloun, Z.;
et al. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. Molecules 2022, 27, 2048.
https://doi.org/10.3390/molecules27072048
AMA Style
El-Arif G, Khazaal S, Farhat A, Harb J, Annweiler C, Wu Y, Cao Z, Kovacic H, Abi Khattar Z, Fajloun Z,
et al. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. Molecules. 2022; 27(7):2048.
https://doi.org/10.3390/molecules27072048
Chicago/Turabian Style
El-Arif, George, Shaymaa Khazaal, Antonella Farhat, Julien Harb, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Hervé Kovacic, Ziad Abi Khattar, Ziad Fajloun,
and et al. 2022. "Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases" Molecules 27, no. 7: 2048.
https://doi.org/10.3390/molecules27072048
APA Style
El-Arif, G., Khazaal, S., Farhat, A., Harb, J., Annweiler, C., Wu, Y., Cao, Z., Kovacic, H., Abi Khattar, Z., Fajloun, Z., & Sabatier, J.-M.
(2022). Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases. Molecules, 27(7), 2048.
https://doi.org/10.3390/molecules27072048